Skip to content

Amyotrophic Lateral Sclerosis 27 Juvenile C5830359

Published: July 22, 2026Updated: August 20, 2026

A rare inherited form of ALS that begins in childhood or adolescence, causing progressive muscle weakness. It affects motor neurons and typically advances over time, with care focused on supporting function and quality of life.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G12.21
ICD-11
8A00.0
Body system
neurologic
Severity
fatal
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Generalized symptoms

Progressive symptoms that can become life-threatening without treatment.

Seek immediate medical attention if symptoms worsen.

!

Progressive muscle weakness

Muscle atrophy

(neurologic)

Spasticity

(neurologic)

Joint contractures

(musculoskeletal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Outpatient procedure with monitoring

Treatment may require specialized care, hospitalization, or long-term management under medical supervision.

procedure
2

Specialized juvenile ALS multidisciplinary care

Longitudinal care at a center experienced with juvenile ALS, coordinating neurology, pulmonology, physical medicine, psychology, and educational support services tailored to developmental needs.

monitoring
3

Disease-modifying therapy consideration

Riluzole may be considered following careful discussion of limited pediatric-specific data. Benefits should be weighed against potential side effects in young patients.

medication

Additional treatment options

Adaptive physical rehabilitation

Ongoing physical and occupational therapy with focus on preserving motor function, managing spasticity, and implementing adaptive technologies as disease progresses.

physical_therapy

Psychosocial support for patient and family

Age-appropriate psychological counseling addressing the unique emotional challenges of juvenile-onset disease. Includes support for siblings and family system functioning.

psychological

Respiratory surveillance program

Regular monitoring of respiratory function appropriate for juvenile patients. Nocturnal hypoventilation monitoring with gradual introduction of respiratory support options.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

Call emergency services (911) immediately

!

Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.

Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.

Frequently asked questions

Common questions about this topic.

Q

What is Amyotrophic Lateral Sclerosis 27 Juvenile C5830359?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Andersen PM, et al. Guidelines for the management of amyotrophic lateral sclerosis. Neurology. 2021.

guideline2021
2

Brown RH, et al. Juvenile onset amyotrophic lateral sclerosis: clinical features and pathophysiology. Lancet Neurology. 2019.

review2019
3

Clement G, et al. SOD1 gene mutations in juvenile ALS patients. J Neurol Neurosurg Psychiatry. 2020.

clinical_trial2020
4

Ingre C, et al. Risk factors for ALS: a systematic review and meta-analysis. Neurology. 2018.

meta_analysis2018

Medication Comparisons

Compare medications used to treat Amyotrophic Lateral Sclerosis 27 Juvenile C5830359. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy